推薦產品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 揚農化工發(fā)布2016年一季報,實現營業(yè)收入8.18億元,同比下降11.13%;營業(yè)利潤1.16億元,同比下降21.95%;歸屬于上市公司股東的凈利潤9510.18萬元,同比下降21.27%,扣除非經常性損益后的凈利潤9311.40萬元,同比下降20.84%。按3.10億股的總股本計,實現每股收益0.31元(扣非后為0.30元),每股經營現金流為0.37元。
公司一季度營業(yè)收入同比下降11.13%,主要受累于除草劑業(yè)務收入同比下降,公司除草劑產品主要直供海外大客戶,由于農藥行業(yè)景氣目前整體偏弱,公司客戶庫存水平偏高,一季度采購量和采購價格均有所下降;而公司菊酯產品銷售總體穩(wěn)定。由于毛利率水平相對較低的草甘膦銷售占比的下降,及公司衛(wèi)生用菊酯專利品種盈利水平的提升,公司綜合毛利率同比提升1.76個百分點至27.0%。公司期間費用率同比提升3.14個百分點至9.6%,其中管理費用率、財務費用率分別同比提升1.63、1.57個百分點,銷售費用率同比基本維持穩(wěn)定。
公司如東二期項目(主要包括20000噸/年麥草畏等產品)目前已開工建設,明年上半年有望陸續(xù)投產,預計伴隨相關轉基因種子的推廣、以及相關制劑應用在美評估結束,麥草畏市場有望逐步啟動,上述項目有望構成公司2017年除草劑業(yè)務重要的增長點。
